Regeneron (REGN) affirms FY16 Eylea guidance - Bloomberg
Get Alerts REGN Hot Sheet
Price: $962.49 -0.39%
Revenue Growth %: +1.9%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
SHIM, KOD, HEWA, More
Revenue Growth %: +1.9%
Financial Fact:
Loss from operations: 362.8M
Today's EPS Names:
SHIM, KOD, HEWA, More
Join SI Premium – FREE
Regeneron (NASDAQ: REGN) affirms FY16 Eylea guidance, according to Bloomberg, citing conference commentary today. The company stated that it was "just being realistic."
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BYD Targets 20% Jump in Annual Sales - Reuters
- Torrid Holdings Inc. (CURV) Tops Q4 EPS by 4c, provides guidance
- P3 Health Partners Inc. (PIII) Misses Q4 EPS by 14c, reaffirms guidance
Create E-mail Alert Related Categories
Guidance, Trader TalkSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!